CompletedNCT05571592
Official study titleRandomized Placebo-controlled Trial to Determine the Biological Signature of Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
This study has finished and is no longer accepting participants.
In New YorkAnxietyMedication studyAges 18–45
- Countries
- United States
- Sponsor
- NYU Langone Health
CompletedNCT05868135
Official study titleGuided Internet-delivered Treatment for Moderate Depression, Social Anxiety Disorder and Panic Disorder - An Open Naturalistic Multicentre Cost-effectiveness Trial
This study has finished and is no longer accepting participants.
Multiple locations, including BergenAnxiety, DepressionObservational studyAges 18+
- Countries
- Norway
- Sponsor
- St. Olavs Hospital
CompletedNCT06693609
What is this study about?Researchers compared EMP-01 and placebo, tracking side effects to assess safety and tolerability in adults with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including BridgetownAnxietyMedication studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- atai Therapeutics, Inc.
Active Not RecruitingNCT06615557
Official study titleUS, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)
This study is no longer accepting new participants.
Multiple locations, including PhoenixAnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- VistaGen Therapeutics, Inc.
CompletedNCT06145490
Official study titleAdenosine Receptors From Genes to Behavior: Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance, Decision-Making and Interoception in Healthy Individuals and Panic Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including LundAnxietyPlacebo researchAges 18–65
- Countries
- Sweden
- Sponsor
- Uppsala University
CompletedNCT03821779
Official study titleStudy of Slow Prefrontal Cortex Oscillations During Social Exposure in Social Anxiety Disorder
This study has finished and is no longer accepting participants.
In BordeauxAnxietyStudy assessmentsAges 20–50
- Countries
- France
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
CompletedNCT07464561
Official study titleREcover Spaces for Traumatized Children in CommUnity sEttings Post COVID-19 (RESCCUE4): A Double-Blind Controlled Trial Comparing Group Cognitive Behavioral Therapy Versus Treatment as Usual in Adolescents With Social Anxiety Disorder
This study has finished and is no longer accepting participants.
In RomaAnxietyBehavioural studyAges 12–17
- Countries
- Italy
- Sponsor
- Bambino Gesù Hospital and Research Institute
Active Not RecruitingNCT07221578
What is this study about?Researchers are comparing VQW-765 and placebo, tracking side effects to assess safety in people with an anxiety condition.
This study is no longer accepting new participants.
Multiple locations, including PhoenixAnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Vanda Pharmaceuticals
CompletedNCT07099521
Official study titleThe Effects of High-definition Transcranial Direct Current Stimulation on Cognitive Bias Among Individuals With Social Anxiety Symptoms
This study has finished and is no longer accepting participants.
In GuangzhouAnxietyDevice studyAges 18–24
- Countries
- China
- Sponsor
- South China Normal University
CompletedNCT07299045
Official study titleThe Impact of Mindfulness-Based Psychoeducation on Perceived Stress, Intolerance of Uncertainty, and Cognitive Flexibility in Patients With Anxiety Disorders: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In AydinAnxietyInterventional studyAges 18–80
- Countries
- Türkiye
- Sponsor
- Aydin Adnan Menderes University
CompletedNCT05964231
Official study titleA Double-blind Randomized Controlled Trial Investigating Associations of Microbiota, Serum Total Antioxidant Capacity and Sleep or Psychiatric Symptoms Before and After the Intake of Psychobiotic Lactobacillus Paracasei
This study has finished and is no longer accepting participants.
In TaipeiAnxietyPlacebo comparisonAges 20–70
- Countries
- Taiwan
- Sponsor
- Mackay Memorial Hospital
CompletedNCT06526260
This study has finished and is no longer accepting participants.
In Los AngelesAnxietyBehavioural studyAges 16–22
- Countries
- United States
- Sponsor
- Children's Hospital Los Angeles